Estrogen in Prostate Cancer - Friend or Foe?

Publisher： Bentham Science Publishers

E-ISSN： 1875-6301|2|4|341-349

ISSN： 1573-3947

Source： Current Cancer Therapy Reviews, Vol.2, Iss.4, 2006-11, pp. : 341-349

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The role of inflammation in progression of breast cancer: Friend or foe? (Review)

By    

International Journal of Oncology, Vol. 47, Iss. 3, 2015-01 ,pp. : 797-805

Spandidos Publications

Access to resources Recommend Favorite

Urinary estrogen metabolites and prostate cancer: a case–control study in the United States

By Muti P.  

Cancer Causes and Control, Vol. 13, Iss. 10, 2002-12 ,pp. : 947-955

Springer Publishing Company

Access to resources Recommend Favorite

Estrogen and Cancer

By Creasman W.T.  

Gynecologic Oncology, Vol. 86, Iss. 1, 2002-07 ,pp. : 1-9

Academic Press

Access to resources Recommend Favorite

Differential effects of estrogen receptor ligands on regulation of dihydrotestosterone-induced cell proliferation in endothelial and prostate cancer cells

By              

International Journal of Oncology, Vol. 42, Iss. 1, 2013-01 ,pp. : 327-337

Spandidos Publications

Access to resources Recommend Favorite

The estrogen receptor signaling pathway activated by phthalates is linked with transforming growth factor-β in the progression of LNCaP prostate cancer models

By      

International Journal of Oncology, Vol. 45, Iss. 2, 2014-01 ,pp. : 595-602

Spandidos Publications

Access to resources Recommend Favorite